EA201690057A1 - Остеопонтин молока млекопитающих для повышения иммунологической реактивности - Google Patents
Остеопонтин молока млекопитающих для повышения иммунологической реактивностиInfo
- Publication number
- EA201690057A1 EA201690057A1 EA201690057A EA201690057A EA201690057A1 EA 201690057 A1 EA201690057 A1 EA 201690057A1 EA 201690057 A EA201690057 A EA 201690057A EA 201690057 A EA201690057 A EA 201690057A EA 201690057 A1 EA201690057 A1 EA 201690057A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- osteopontin
- milk
- mammal
- mammals
- infectious disease
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 8
- 102000004264 Osteopontin Human genes 0.000 title abstract 5
- 108010081689 Osteopontin Proteins 0.000 title abstract 5
- 239000008267 milk Substances 0.000 title abstract 4
- 210000004080 milk Anatomy 0.000 title abstract 4
- 235000013336 milk Nutrition 0.000 title abstract 4
- 230000001900 immune effect Effects 0.000 title abstract 2
- 230000009257 reactivity Effects 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Раскрытое изобретение касается остеопонтина молока млекопитающего, и/или его активного укороченного варианта, или его активного пептида для улучшения иммунологической реактивности к инфекционному заболеванию у млекопитающего, например у субъекта-человека, а также повышения эффективности вакцинации для профилактического или терапевтического лечения инфекционного заболевания у млекопитающих, таких как люди. Изобретение дополнительно предусматривает вакцинную систему для применения в профилактическом или терапевтическом лечении инфекционного заболевания у млекопитающего, содержащую вакцину и остеопонтин молока млекопитающих, и/или его активный укороченный вариант, или его активный пептид, для перорального введения млекопитающему, а также способы повышения иммунорезистентности к инфекционному заболеванию у млекопитающего путем введения вакцины и остеопонтина молока млекопитающих и/или его активного укороченного варианта.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843185P | 2013-07-05 | 2013-07-05 | |
| EP13175267 | 2013-07-05 | ||
| PCT/EP2014/064339 WO2015001092A1 (en) | 2013-07-05 | 2014-07-04 | Mammalian milk osteopontin for enhancing immune responsiveness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201690057A1 true EA201690057A1 (ru) | 2016-07-29 |
| EA034654B1 EA034654B1 (ru) | 2020-03-03 |
Family
ID=48740972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201690057A EA034654B1 (ru) | 2013-07-05 | 2014-07-04 | Применение остеопонтина коровьего молока для повышения иммунорезистентности |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9956283B2 (ru) |
| EP (1) | EP3016673B1 (ru) |
| JP (1) | JP6509833B2 (ru) |
| KR (1) | KR102307002B1 (ru) |
| CN (1) | CN105407910B (ru) |
| AU (1) | AU2014286123B2 (ru) |
| BR (1) | BR112016000067B1 (ru) |
| CA (1) | CA2916821C (ru) |
| CL (1) | CL2015003803A1 (ru) |
| DK (1) | DK3016673T3 (ru) |
| EA (1) | EA034654B1 (ru) |
| ES (1) | ES2656474T3 (ru) |
| MX (1) | MX369925B (ru) |
| NZ (1) | NZ715430A (ru) |
| PH (1) | PH12015502844A1 (ru) |
| PL (1) | PL3016673T3 (ru) |
| PT (1) | PT3016673T (ru) |
| WO (1) | WO2015001092A1 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019207355A1 (en) * | 2018-04-25 | 2019-10-31 | Health And Happiness (H&H) Hong Kong Limited | Combinations of osteopontin and 2'-fucosyllactose for use as medicaments |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN113424962A (zh) * | 2020-09-21 | 2021-09-24 | 黑龙江飞鹤乳业有限公司 | 提高免疫力的营养组分、含有其的食品或保健品及其用途 |
| CN113475720B (zh) * | 2021-06-15 | 2023-07-25 | 合生元（广州）健康产品有限公司 | 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用 |
| WO2023144416A1 (en) * | 2022-01-31 | 2023-08-03 | Société des Produits Nestlé S.A. | Compositions comprising osteopontin (opn) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056405A1 (en) * | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
| JP2002512627A (ja) * | 1997-06-11 | 2002-04-23 | アコーダ セラピーティックス | Ｃｎｓ神経再生組成物及びその使用方法 |
| MXPA01010332A (es) * | 1999-04-15 | 2002-09-18 | Childrens Medical Center | Metodos y composiciones para modular una respuesta inmunitaria. |
| WO2001049741A2 (en) | 2000-01-07 | 2001-07-12 | Arla Foods Amba | A process for isolation of osteopontin from milk |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| AU2003239589A1 (en) * | 2002-05-24 | 2003-12-12 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
| KR20140073591A (ko) * | 2003-09-18 | 2014-06-16 | 아를라 푸즈 에이엠비에이 | 유아용 조제유 |
| JP4509114B2 (ja) * | 2003-09-18 | 2010-07-21 | アルラ・フーズ・エイ・エム・ビィ・エイ | 幼児用調製乳 |
| KR20090123115A (ko) * | 2008-05-27 | 2009-12-02 | 한국생명공학연구원 | 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법 |
| KR101940830B1 (ko) * | 2011-03-03 | 2019-01-21 | 아를라 푸즈 에이엠비에이 | 농축된 원료를 이용한 오스테오폰틴의 단리 방법 |
| KR20140104474A (ko) * | 2011-12-07 | 2014-08-28 | 포사이스 덴탈 인퍼머리 포 칠드런 (디.비.에이. 더 포사이스 인스티튜트) | 종양 성장의 억제 또는 예방에 사용하기 위한 오스테오폰틴 변이체 및 상기 오스테오폰틴 변이체를 함유하는 조성물 |
-
2014
- 2014-07-04 EA EA201690057A patent/EA034654B1/ru not_active IP Right Cessation
- 2014-07-04 MX MX2016000107A patent/MX369925B/es active IP Right Grant
- 2014-07-04 CA CA2916821A patent/CA2916821C/en active Active
- 2014-07-04 CN CN201480038124.7A patent/CN105407910B/zh active Active
- 2014-07-04 ES ES14735964.0T patent/ES2656474T3/es active Active
- 2014-07-04 PT PT147359640T patent/PT3016673T/pt unknown
- 2014-07-04 EP EP14735964.0A patent/EP3016673B1/en active Active
- 2014-07-04 AU AU2014286123A patent/AU2014286123B2/en active Active
- 2014-07-04 DK DK14735964.0T patent/DK3016673T3/da active
- 2014-07-04 NZ NZ715430A patent/NZ715430A/en unknown
- 2014-07-04 KR KR1020167002892A patent/KR102307002B1/ko active IP Right Grant
- 2014-07-04 US US14/903,049 patent/US9956283B2/en active Active
- 2014-07-04 PL PL14735964T patent/PL3016673T3/pl unknown
- 2014-07-04 BR BR112016000067-6A patent/BR112016000067B1/pt active IP Right Grant
- 2014-07-04 WO PCT/EP2014/064339 patent/WO2015001092A1/en active Application Filing
- 2014-07-04 JP JP2016522645A patent/JP6509833B2/ja active Active
-
2015
- 2015-12-21 PH PH12015502844A patent/PH12015502844A1/en unknown
- 2015-12-31 CL CL2015003803A patent/CL2015003803A1/es unknown
-
2018
- 2018-04-04 US US15/945,517 patent/US10772955B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK3016673T3 (da) | 2018-01-29 |
| MX2016000107A (es) | 2016-06-07 |
| CA2916821C (en) | 2023-10-03 |
| EA034654B1 (ru) | 2020-03-03 |
| JP2016529217A (ja) | 2016-09-23 |
| US9956283B2 (en) | 2018-05-01 |
| CN105407910A (zh) | 2016-03-16 |
| US20160136268A1 (en) | 2016-05-19 |
| PH12015502844B1 (en) | 2016-03-28 |
| US20180289798A1 (en) | 2018-10-11 |
| BR112016000067A2 (ru) | 2017-09-05 |
| ES2656474T3 (es) | 2018-02-27 |
| MX369925B (es) | 2019-11-25 |
| CA2916821A1 (en) | 2015-01-08 |
| CN105407910B (zh) | 2019-12-03 |
| NZ715430A (en) | 2022-01-28 |
| PH12015502844A1 (en) | 2016-03-28 |
| EP3016673B1 (en) | 2017-10-25 |
| KR20160030960A (ko) | 2016-03-21 |
| PL3016673T3 (pl) | 2018-04-30 |
| JP6509833B2 (ja) | 2019-05-08 |
| WO2015001092A1 (en) | 2015-01-08 |
| AU2014286123A1 (en) | 2016-01-21 |
| US10772955B2 (en) | 2020-09-15 |
| KR102307002B1 (ko) | 2021-10-05 |
| BR112016000067B1 (pt) | 2022-08-30 |
| EP3016673A1 (en) | 2016-05-11 |
| CL2015003803A1 (es) | 2016-08-05 |
| AU2014286123B2 (en) | 2019-02-28 |
| PT3016673T (pt) | 2018-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201690057A1 (ru) | Остеопонтин молока млекопитающих для повышения иммунологической реактивности | |
| EA201300558A1 (ru) | Соединения и способы для купирования боли | |
| CU20100216A7 (es) | Polipéptidos derivados de la il-2 con actividad agonista y mayor eficacia para la terapia del cáncer e infecciones crónicas | |
| EA201071365A1 (ru) | Моноклональные антитела, имеющие гомоподтип кросс-нейтрализующих свойств против вируса гриппа а подтипа н1 | |
| EA202090699A3 (ru) | Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения | |
| EA201590655A1 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
| EA201490610A1 (ru) | Соединения и способы усиления врожденных иммунных ответов | |
| EA201171032A1 (ru) | Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами | |
| EA201490538A1 (ru) | Лечение кашля и его приступов | |
| EA201691443A1 (ru) | Накожное восстановление иммунобаланса | |
| EA201591701A1 (ru) | Комбинация противовирусных препаратов прямого действия и рибавирина для лечения пациентов с hcv | |
| EA201391200A1 (ru) | Способы и композиции для вакцинации от staphylococcus aureus | |
| EA201692279A1 (ru) | Способ уменьшения иммуногенности белка и пептида | |
| RU2014127714A (ru) | ВАКЦИНА НА ОСНОВЕ ТОКСИНОВ Clostridium difficile | |
| EA201300136A1 (ru) | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида | |
| CY1123583T1 (el) | Ανοσογονος συνθεση για χρηση στη θεραπεια | |
| WO2015054678A3 (en) | Human papilloma virus therapeutic vaccine | |
| EA201390617A1 (ru) | Пептиды фактора viii для индукции иммунной толерантности и иммунодиагностики | |
| EA201590111A1 (ru) | Моноклональное антитело человека против белка vp1 вируса jc | |
| EA201690115A1 (ru) | Комбинированные иммуногенные композиции | |
| SG10201908089VA (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| EA201401352A1 (ru) | Вакцина против вируса шмалленберга (sbv), способы ее получения и применения | |
| EA201170569A1 (ru) | Лекарственное средство для повышения дозы противоаллергической вакцины | |
| TR201901846T4 (tr) | Aşı terapisi. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |